MAPPP
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today
Description
Despite the considerable efficacy of antithrombotics and the increased number of oral anticoagulants now available, preventable bleeding and thrombotic events are still unacceptably common. While recently marketed agents require less laboratory monitoring, problems with the clinical management of anticoagulated patients persist, particularly in the peri-procedural period.
Surgery and invasive medical interventions increase the risk of bleeding, while withholding anticoagulants increases the risk of thrombosis due to the underlying condition(s) for which anticoagulation was originally prescribed. The clinical team must therefore balance these competing risks and make educated decisions regarding the decision to interrupt oral anticoagulation for a medical procedure and, if interrupted, whether to "bridge" anticoagulation with injectable anticoagulants, such as low molecular weight heparin (LMWH) in warfarin treated patients.
This guide is intended to:
-Assist clinicians in the simultaneous evaluation of procedure-related bleeding risk and underlying risk of thrombosis
-Guide decisions regarding the interruption of anticoagulation and the use of anticoagulant "bridging"
-Provide detailed guidance for drug dosing and laboratory monitoring in the peri-procedural period
-Encourage clear communication between clinicians involved in prescribing anticoagulants and performing invasive procedures
This material was created by the multidisciplinary members of the Peri-Procedural Task Force of the New York State Anticoagulation Coalition and IPRO, the Medicare Quality Improvement Organization for New York State, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents do not necessarily reflect CMS policy. 10SOW-NY-AIM-7.3-14-01
Hide..
Show more..
Surgery and invasive medical interventions increase the risk of bleeding, while withholding anticoagulants increases the risk of thrombosis due to the underlying condition(s) for which anticoagulation was originally prescribed. The clinical team must therefore balance these competing risks and make educated decisions regarding the decision to interrupt oral anticoagulation for a medical procedure and, if interrupted, whether to "bridge" anticoagulation with injectable anticoagulants, such as low molecular weight heparin (LMWH) in warfarin treated patients.
This guide is intended to:
-Assist clinicians in the simultaneous evaluation of procedure-related bleeding risk and underlying risk of thrombosis
-Guide decisions regarding the interruption of anticoagulation and the use of anticoagulant "bridging"
-Provide detailed guidance for drug dosing and laboratory monitoring in the peri-procedural period
-Encourage clear communication between clinicians involved in prescribing anticoagulants and performing invasive procedures
This material was created by the multidisciplinary members of the Peri-Procedural Task Force of the New York State Anticoagulation Coalition and IPRO, the Medicare Quality Improvement Organization for New York State, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents do not necessarily reflect CMS policy. 10SOW-NY-AIM-7.3-14-01
Screenshots
User Rating
0 out of 5
0 ratings in Vietnam
Ratings History
Reviews
App doesn't have any reviews yet
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
Users may also like
| Name | Reviews | Recent release | |
|---|---|---|---|
Contraception Point-of-Care
Joshua Steinberg & RHAP
|
0
|
1 month ago | |
Anticoagulation Manager
|
0
|
1 year ago | |
MKSAP 19
|
0
|
1 month ago | |
JiTT Infographics
Tools for Medical Education
|
0
|
1 month ago | |
ManageAnticoag
|
0
|
8 months ago | |
AnticoagEvaluator
|
0
|
6 months ago | |
MAQI2 Anticoagulation Toolkit
|
0
|
1 month ago | |
Preop Eval
|
0
|
1 year ago | |
ASH Pocket Guides
|
0
|
3 months ago | |
Aspirin Guide
|
0
|
2 years ago |
Show More
Revenue and Downloads
Gain valuable insights into MAPPP performance with our analytics. Sign up now
to
access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Island Peer Review Organization, Inc
- Languages
- English
- Recent version
- 1.2.71 (1 year ago )
- Released on
- Mar 18, 2016 (8 years ago )
- Also available in
- United States, Mexico, Poland, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Italy, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Turkey, Taiwan, Ukraine, Vietnam, South Africa, Ecuador, Argentina, Australia, Azerbaijan, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Denmark, United Arab Emirates, Egypt, Spain, Finland, France, United Kingdom, Greece, Hong Kong, Hungary, Indonesia, Ireland, Israel, India
- Last updated
- 1 month ago